Kidney Care Community News

Diality Inc. has raised $28 million to advance its mobile hemodialysis system through regulatory and clinical review, according to a company press release.

Patients with reduced kidney function who are discharged without clinically evident residual disease had an 18% increase in mortality a year after hospitalization, data show.

Healthmap Solutions Inc. has raised $100 million to advance its kidney disease-focused population health management business, nearly tripling the size of a spring 2022 funding round, according to a press release.

Outset Medical stock value took a significant downturn after the company announced in its second-quarter earnings report that it was pausing shipment of its TabloCart to obtain FDA 510(k) approval.

Quanta Dialysis Technologies has received FDA 510(k) clearance for an expanded version of the Quanta Dialysis System hemodialysis device, according to a press release.

A new educational patient-decision aid received high acceptability ratings from older adults with kidney disease and their caregivers, according to published data.

In a joint statement, the American Society of Nephrology and National Kidney Foundation expressed concern about the United States Preventive Services Task Force final research plan for chronic kidney disease.

The FDA has approved the use of Veklury for the treatment of COVID-19 in patients with severe renal impairment, including those on dialysis, according to a press release from drug manufacturer Gilead Sciences Inc.

Rockwell Medical Inc. has acquired the hemodialysis concentrates business of Evoqua Water Technologies, making the company “the leading supplier of liquid bicarbonate products” to dialysis centers in the U.S., according to a press release.

Outset Medical Inc. reported in a recent 8-K filing that it had received a warning letter from the FDA expressing concerns about the company’s marketing of its Tablo dialysis machine and other products.